Insider-Owned Growth Leaders To Know In June 2026
EHang Holdings Limited EH | 0.00 |
Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has risen by 21% over the past year with earnings forecasted to grow by 19% annually. In this context of fluctuating performance and promising growth prospects, identifying companies with high insider ownership can be crucial as it often indicates strong confidence from those who know the business best.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Uxin (UXIN) | 34.3% | 69.4% |
| Upstart Holdings (UPST) | 14.1% | 58.5% |
| OS Therapies (OSTX) | 12.4% | 72.1% |
| Karman Holdings (KRMN) | 15.6% | 52.6% |
| FirstSun Capital Bancorp (FSUN) | 21% | 54.2% |
| Corcept Therapeutics (CORT) | 10.9% | 48.9% |
| Circle Internet Group (CRCL) | 11.8% | 49% |
| Astera Labs (ALAB) | 10% | 29.4% |
| AppLovin (APP) | 27.2% | 22% |
| Allegiant Travel (ALGT) | 10% | 133.7% |
Underneath we present a selection of stocks filtered out by our screen.
Corcept Therapeutics (CORT)
Simply Wall St Growth Rating: ★★★★★★
Overview: Corcept Therapeutics Incorporated is a biopharmaceutical company focused on discovering and developing medications for severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States, with a market cap of $8.56 billion.
Operations: The company's revenue segment is the discovery, development, and commercialization of pharmaceutical products, generating $769.10 million.
Insider Ownership: 10.9%
Revenue Growth Forecast: 24.4% p.a.
Corcept Therapeutics shows strong growth potential with high insider ownership, despite recent financial challenges. The company's revenue is expected to grow significantly faster than the US market, and its earnings are forecasted to increase substantially over the next three years. Recent developments include a resubmission of its New Drug Application for relacorilant and positive trial results for Lifyorli in treating ovarian cancer, indicating promising advancements in its product pipeline.
Strive (ASST)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Strive, Inc. is a privately owned investment manager with a market cap of $1.09 billion.
Operations: The company's revenue is derived from Asset Management, amounting to $5.57 million.
Insider Ownership: 14.0%
Revenue Growth Forecast: 19.5% p.a.
Strive Asset Management, LLC demonstrates growth potential with substantial insider ownership. Despite recent financial losses, including a net loss of US$265.91 million in Q1 2026, the company is expected to become profitable within three years and outpace average market profit growth. Revenue grew by 63.4% last year and is forecasted to rise at 19.5% annually, surpassing the US market rate of 13%. The company's share price has been highly volatile recently.
EHang Holdings (EH)
Simply Wall St Growth Rating: ★★★★★☆
Overview: EHang Holdings Limited is a technology platform company specializing in urban air mobility across various regions including China, East Asia, West Asia, North America, South America, West Africa, and Europe with a market cap of approximately $533.19 million.
Operations: The company's revenue primarily comes from its Aerospace & Defense segment, totaling CN¥417.55 million.
Insider Ownership: 28.1%
Revenue Growth Forecast: 32.1% p.a.
EHang Holdings is poised for growth with high insider ownership, despite recent financial losses. The company is forecasted to achieve profitability within three years and expects revenue to grow at 32.1% annually, outpacing the US market. EHang's involvement in Hong Kong’s Low-Altitude Economy initiative highlights its innovative edge in eVTOL applications. Recent strategic moves include a US$30 million share repurchase program, although the stock has experienced significant volatility recently.
Key Takeaways
- Explore the 170 names from our Fast Growing US Companies With High Insider Ownership screener here.
- Looking For Alternative Opportunities? Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
